THU0209 Characterization of Changes in Lymphocyte Subsets in Baricitinib-Treated Patients with Rheumatoid Arthritis in A Phase 3 Study (RA-BEAM): Table 1

MLA

Michael E. Weinblatt, et al. “THU0209 Characterization of Changes in Lymphocyte Subsets in Baricitinib-Treated Patients with Rheumatoid Arthritis in A Phase 3 Study (RA-BEAM): Table 1.” Annals of the Rheumatic Diseases, vol. 75, June 2016, p. 262.3-263. EBSCOhost, https://doi.org/10.1136/annrheumdis-2016-eular.1513.

APA

Michael E. Weinblatt, William L. Macias, S. Thanabalasundrum, E.C. Keystone, Terence Rooney, Douglas E Schlichting, Maher Issa, R.M. Fleischmann, Steven H. Zuckerman, Michael Schiff, P. Taylor, B. Augendre-Ferrante, Yoshiya Tanaka, S. de Bono, & T. Takeuchi. (2016). THU0209 Characterization of Changes in Lymphocyte Subsets in Baricitinib-Treated Patients with Rheumatoid Arthritis in A Phase 3 Study (RA-BEAM): Table 1. Annals of the Rheumatic Diseases, 75, 262.3-263. https://doi.org/10.1136/annrheumdis-2016-eular.1513

Chicago

Michael E. Weinblatt, William L. Macias, S. Thanabalasundrum, E.C. Keystone, Terence Rooney, Douglas E Schlichting, Maher Issa, et al. 2016. “THU0209 Characterization of Changes in Lymphocyte Subsets in Baricitinib-Treated Patients with Rheumatoid Arthritis in A Phase 3 Study (RA-BEAM): Table 1.” Annals of the Rheumatic Diseases 75 (June): 262.3-263. doi:10.1136/annrheumdis-2016-eular.1513.